ONY Biotech
Jonathan Miller joined the ONY Biotech team in Commercial Sales in June 2012, and assumed the role of Director of U.S. Sales in February 2017.
Miller has over 17 years of experience in the pharmaceutical and biopharmaceutical industry in sales, sales training, national accounts, and sales management. Having started his career in the pharmaceutical industry with Forest Laboratories and Sanofi-Synthelabo (now Sanofi Aventis), he transitioned to smaller biopharmaceutical companies where he found his true passion in the development and growth of this market segment.
Miller is responsible for the growth and development of the U.S. sales market.
This person is not in any offices
ONY Biotech
A small, privately-held, and family-focused neonatology pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. They innovate with a singular purpose: to improve outcomes for premature babies and their families.